As the opioid crisis worsens, one Boston-based pharmaceutical company has used some impressive biology to create a non-addictive, non-opioid painkiller. As the New York Times reports, Vertex Pharmaceuticals seems to have shown some extremely promising results in Phase 3 clinical trials, announced earlier this week in a statement, for patients who experienced "moderate-to-severe acute pain" after […]